4/12
12:07 pm
pyxs
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect? [Yahoo! Finance]
Low
Report
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect? [Yahoo! Finance]
4/10
08:06 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/28
04:43 pm
pyxs
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
High
Report
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/28
04:30 pm
pyxs
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/28
12:15 am
pyxs
Pyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Wait [Seeking Alpha]
Low
Report
Pyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Wait [Seeking Alpha]
3/27
07:44 am
pyxs
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights [Yahoo! Finance]
Medium
Report
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights [Yahoo! Finance]
3/27
07:30 am
pyxs
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
Medium
Report
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
3/26
01:57 pm
pyxs
All You Need to Know About Pyxis Oncology (PYXS) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Pyxis Oncology (PYXS) Rating Upgrade to Buy [Yahoo! Finance]
3/22
11:20 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
3/22
08:07 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at HC Wainwright from $4.00 to $7.00. They now have a "buy" rating on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at HC Wainwright from $4.00 to $7.00. They now have a "buy" rating on the stock.
3/21
11:50 am
pyxs
Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10 [Seeking Alpha]
High
Report
Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10 [Seeking Alpha]
3/21
07:40 am
pyxs
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 [Yahoo! Finance]
Medium
Report
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 [Yahoo! Finance]
3/21
07:30 am
pyxs
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
Medium
Report
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
3/21
07:06 am
pyxs
Biosion to Present Three Posters at the 2024 AACR Meeting [Yahoo! Finance]
Medium
Report
Biosion to Present Three Posters at the 2024 AACR Meeting [Yahoo! Finance]
3/14
08:12 am
pyxs
Rice Biotech Launch Pad adds William McKeon to external advisory board [Yahoo! Finance]
High
Report
Rice Biotech Launch Pad adds William McKeon to external advisory board [Yahoo! Finance]
3/13
08:00 am
pyxs
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
Medium
Report
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
3/7
04:30 pm
pyxs
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
High
Report
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
3/5
04:56 pm
pyxs
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting [Yahoo! Finance]
Low
Report
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting [Yahoo! Finance]
3/5
04:45 pm
pyxs
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
Low
Report
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
2/27
08:04 am
pyxs
Pyxis Oncology Announces $50 Million Private Placement [Yahoo! Finance]
Medium
Report
Pyxis Oncology Announces $50 Million Private Placement [Yahoo! Finance]
2/27
08:00 am
pyxs
Pyxis Oncology Announces $50 Million Private Placement
High
Report
Pyxis Oncology Announces $50 Million Private Placement
2/9
07:11 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.